RxDoctor Payments Data

Ahmed Abdelfadil, MD

Pulmonary Disease · Tampa, FLNPI 1023072709

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,181 of the $1,475 with a category attached, or 80.0%. It is spread thinly across 15 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $578 and has fallen 53.5% since, to $269 in 2025. That places this record below the midpoint for pulmonary disease clinicians in FL, where the typical reported total is $2,936.

$1,475in general payments, 2019–2025

Across 55 payments — averaging $26.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$316
  • GSK$298
  • Inspire Medical Systems, Inc.$262
  • Philips North America LLC$158
  • Harmony Biosciences LLC$157
  • ANI Pharmaceuticals, Inc.$53
  • plus $233 from 9 others

What the payments were for

  • Food & beverage$1,18180%
  • Education$29520%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,475 in reported general payments places this provider in the 35th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida →

Medicare billing

Part B allowed, 2024
$13,222
Medicare patients
28
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →